Comprehensive Cancer Centers welcomes experienced oncologist and research scientist, Kyaw Zin Thein, MD to its team of medical oncologists serving Southern Nevada.
In its continuing efforts to lead the way in cancer care for the Southern Nevada community, Comprehensive Cancer Centers welcomes Kyaw Zin Thein, MD to its team of medical oncologists.
Prior to joining Comprehensive Cancer Centers, Dr. Thein was an Assistant Professor in the Division of Hematology and Medical Oncology at the Oregon Health and Science University (OHSU) / Knight Cancer Institute (KCI). His main clinical interests include thrombosis, head and neck, thyroid, genitourinary and rare cancers. Dr. Thein also specializes in developing novel therapeutics as he co-led the early phase clinical trials (phase 1) program at OHSU. His passions include exploring genetic-driven combinatorial strategies to tackle cancer and improving the outcomes of patients through the implementation of personalized and precise approaches. During his time at OHSU, he served as a local site principal investigator and co-principal investigator on nearly 30 industry-initiated, multi-institutional trials. He also served as a member on the KCI’s Data and Safety Monitoring Committee where he ensured the compliance, quality, and safety of all interventional clinical trials.
Kyaw Zin Thein, MD, completed his medical degree at the Institute of Medicine 1 in Yangon, Myanmar. He then spent three years as an internal medicine resident at Kingsbrook Jewish Medical Center in Brooklyn, New York where he served as a post-graduate year 3 chief resident. Following his residency, he completed two subspecialty fellowships; Oncologic Emergency Medicine and Investigational Cancer Therapeutics (phase 1) at the University of Texas MD Anderson Cancer Center in Houston, Texas, and Hematology and Medical Oncology fellowship training at Texas Tech University Health Sciences Center in Lubbock, Texas where he was elected to serve as a chief fellow in his third year.
Dr. Thein’s work at Comprehensive Cancer Centers will focus on head and neck, thyroid and rare cancers, Genitourinary Malignancies, Investigational Cancer Therapeutics including early phase clinical trials and phase 1 drug development.
He is Board Certified by the American Society of Clinical Oncology, European Society for Medical Oncology, American Association for Cancer Research, Society for Immunotherapy of Cancer, International Association for the Study of Lung Cancer, American Society of Hematology, European Hematology Association, International Society on Thrombosis and Hemostasis, American Medical Association and the American College of Physicians.
A strong advocate and participant in clinical research studies, during Dr. Thein’s time at the Knight Cancer Institute, he served as a local site principal investigator and co-principal investigator on nearly 30 industry-initiated, multi-institutional trials. He also served as a member on the OHSU Knight Data and Safety Monitoring Committee where he ensured the compliance, quality, and safety of all interventional clinical trials.
He believes the natural evolution of biomarker-driven trials is innovative and logical in an era where genetics is helping guide targeted therapy. He advocates for awareness of rare toxicities arising from newer targeted therapies and immunotherapies while promoting health-related quality of life, symptom control and measures for his patients with cancer.
Dr. Thein’s dedication to research and moving the science of cancer care forward extends to extensive publishing – more than 50 peer-reviewed articles and book chapters in various publications including CA: A Cancer Journal for Clinicians, Cancer Discovery, Trends in Cancer, Nature Communications, Annual Review, JCO Precision Oncology, Experimental Hematology & Oncology and Investigational New Drugs. He has also presented more than 150 oral and poster presentations at national and international conferences including American Society of Hematology, European Society for Medical Oncology, American Society of Clinical Oncology, International Association for the Study of Lung Cancer, British Society for Hematology, American Thoracic Society and National Comprehensive Cancer Network, among others.
For a full list of publications, please visit his bio page on the Comprehensive Cancer Website.
When he’s not taking care of patients or conducting research, Dr. Thein loves to spend time with his family, play badminton, hike, read and write.
Comprehensive Cancer Centers Can Help
And if you, or a loved one, requires cancer care, you can schedule an appointment with physicians like Dr. Kyaw Zin Thein to learn more about treatment options available with the physicians at Comprehensive Cancer Center by calling 702-952-3350.
The content in this post is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of qualified health providers with questions you may have regarding medical conditions.
